Biodesix, Inc.

NASDAQ:BDSX

0.7221 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 71.32349.08738.21254.50645.55724.55220.432
Cost of Revenue 013.0114.15430.51821.9986.0744.406
Gross Profit 71.32336.07724.05823.98823.55918.47816.026
Gross Profit Ratio 10.7350.630.440.5170.7530.784
Reseach & Development Expenses 9.5599.98813.10212.78910.81810.4688.188
General & Administrative Expenses 0000030.63725.899
Selling & Marketing Expenses 0061.46250.51734.85730.63725.899
SG&A 80.45167.38761.46250.51734.85730.63725.899
Other Expenses 15.8110.0440.109-0.0090.422-2.379-1.235
Operating Expenses 105.82177.41974.56463.30645.67541.10534.087
Operating Income -34.498-41.342-50.506-39.318-22.116-22.627-23.461
Operating Income Ratio -0.484-0.842-1.322-0.721-0.485-0.922-1.148
Total Other Income Expenses Net -8.433-10.804-14.86-2.219-8.416-3.985-2.705
Income Before Tax -42.931-52.146-65.447-43.159-31.35-30.726-26.166
Income Before Tax Ratio -0.602-1.062-1.713-0.792-0.688-1.251-1.281
Income Tax Expense 0014.9411.3215.1230.6290.211
Net Income -42.931-52.146-80.388-44.48-36.473-31.355-26.166
Net Income Ratio -0.602-1.062-2.104-0.816-0.801-1.277-1.281
EPS -0.33-0.64-1.91-1.63-1.37-1.23-0.99
EPS Diluted -0.33-0.64-1.91-1.63-1.37-1.23-0.99
EBITDA -34.498-37.103-53.778-35.473-20.843-24.925-21.51
EBITDA Ratio -0.484-0.756-1.319-0.722-0.476-0.902-0.858